![]()
|
|
||||||||
| ||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||
Papers In Press, published online ahead of print November 14, 2001
Neurobiology, Pharmacology & Physiology, University of Chicago, Chicago, IL 60637
Corresponding Author: ssisodia{at}drugs.bsd.uchicago.edu
Different mutations in the BRI2 gene cause rare neurodegenerative conditions, termed familial British dementia (FBD) and familial Danish dementia (FDD). The mutant genes encode BRI-L and BRI-D, the precursors of fibrillogenic ABri and ADan peptides, respectively. We previously reported that furin processes both BRI-L and its wild type counterpart, BRI, resulting in the secretion of C terminal peptides; elevated levels of peptides were generated from BRI-L. In the present study, we show that inducible expression of a1-antitrypsin Portland, a furin inhibitor, inhibits the endoproteolysis of BRI and BRI-L in a dose-dependent manner. Moreover, comparison of the activities of several proprotein convertases reveals that furin is most efficient in endoproteolysis of BRI and BRI-L; PACE4, PC6A, PC6B & LPC show much lower activities. Interestingly, LPC also exhibits enhanced cleavage of BRI-L compared to BRI. Finally, we demonstrate that BRI-D is also processed by furin and, like BRI-L, the cleavage of BRI-D is more efficient than that of BRI. Interestingly, while the ABri peptide is detected both intracellularly and in the medium, the ADan peptide accumulates predominantly in intracellular compartments. We propose that intracellular accumulation of amyloidogenic ADan or ABri peptides results in the neuronal damage leading to FDD and FBD, respectively.
J. Biol. Chem, 10.1074/jbc.M108739200
Submitted on September 11, 2001
Revised on November 6, 2001
Accepted on November 14, 2001
Proteolytic processing of familial British dementia associated BRI variants: Evidence for enhanced intracellular accumulation of amyloidogenic peptides
![]()
CiteULike
Complore
Connotea
Del.icio.us
Digg
Reddit
Technorati What's this?
This article has been cited by other articles:
![]() |
L. Martin, R. Fluhrer, K. Reiss, E. Kremmer, P. Saftig, and C. Haass Regulated Intramembrane Proteolysis of Bri2 (Itm2b) by ADAM10 and SPPL2a/SPPL2b J. Biol. Chem., January 18, 2008; 283(3): 1644 - 1652. [Abstract] [Full Text] [PDF] |
||||
![]() |
N. A. TAYLOR, W. J. M. VAN DE VEN, and J. W. M. CREEMERS Curbing activation: proprotein convertases in homeostasis and pathology FASEB J, July 1, 2003; 17(10): 1215 - 1227. [Abstract] [Full Text] [PDF] |
||||
![]() |
J. W. Kelly and W. E. Balch Amyloid as a natural product J. Cell Biol., May 12, 2003; 161(3): 461 - 462. [Abstract] [Full Text] [PDF] |
||||
| HOME | HELP | FEEDBACK | SUBSCRIPTIONS | ARCHIVE | SEARCH |
| All ASBMB Journals | Molecular and Cellular Proteomics |
| Journal of Lipid Research | ASBMB Today |